Alzheimer disease: Donepezil and nursing home placement-benefits and costs

Nature Reviews Neurology

Volumn 12, Issue 1, 2016, Pages 11-13

  Jelic, Vesna ^a   Winblad, Bengt ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DONEPEZIL; INDAN DERIVATIVE; MEMANTINE; NOOTROPIC AGENT; PIPERIDINE DERIVATIVE;

ALZHEIMER DISEASE; COST BENEFIT ANALYSIS; COST CONTROL; DISEASE SEVERITY; DRUG COST; DRUG EFFICACY; FOLLOW UP; HUMAN; MINI MENTAL STATE EXAMINATION; MULTICENTER STUDY (TOPIC); NURSING HOME; PRIORITY JOURNAL; PUBLIC HEALTH; RANDOMIZED CONTROLLED TRIAL (TOPIC); SHORT SURVEY; TREATMENT OUTCOME; FEMALE; HOME FOR THE AGED; MALE;

ALZHEIMER DISEASE; FEMALE; HOMES FOR THE AGED; HUMANS; INDANS; MALE; MEMANTINE; NOOTROPIC AGENTS; NURSING HOMES; PIPERIDINES;

EID: 84952664075     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2015.237     Document Type: Short Survey

References (10)

1. Jelic, V., &Darreh-Shori, T. Donepezil: A review of pharmacological characteristics and role in the management of Alzheimer disease. Clin. Med. Insights Ther. 2, 771-788 (2010
2. Howard, R., et al. Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO AD) trial: Secondary and post-hoc analyses. Lancet Neurol. 14, 1171-1181 (2015
3. Johnell, K., Religa, D., &Eriksdotter, M. Differences in drug therapy between dementia disorders in the Swedish dementia registry: A nationwide study of over 7,000 patients. Dement. Geriatr. Cogn. Disord. 35, 239-248 (2013
4. Birks, J. Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database Syst. Rev. 1, CD005593 (2006
5. Schmidt, R., et al. EFNS ENS/EAN guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's disease. Eur. J. Neurol. 22, 889-898 (2015
6. Wimo, A. Cost effectiveness of cholinesterase inhibitors in the treatment of Alzheimer's disease: A review with methodological considerations. Drugs Aging 21, 279-295 (2004
7. Courtney, C., et al. Long-Term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): Randomised double-blind trial. Lancet 363, 2105-2115 (2004
8. Wimo, A. Long-Term effects of Alzheimer's disease treatment. Lancet Neurol. 14, 1145-1146 (2015
9. Huybrechts, K. F., et al. Variation in antipsychotic treatment choice across US nursing homes. J. Clin. Psychopharmacol. 32, 11-17 (2012
10. Johnell, K., &Fastbom, J. Comparison of prescription drug use between community-dwelling and institutionalized elderly in Sweden. Drugs Aging 29, 751-758 (2012